课题基金 / 基金详情

项目摘要

项目成果

JOSEPH Benjamin RUCKER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):作为动物检测营养丰富的食物和辨别毒素的主要机制,味觉对健康和行为有重大影响。苦味具有高敏感性和广泛的特异性,可以引起强烈的厌恶反应,影响与健康相关的行为,如饮食偏好和药物依从性。相反,甜味有助于检测和消费高碳水化合物(因此高热量)的食物,但过度消费热量会导致肥胖和糖尿病。因此,在许多情况下期望操纵味觉和/或提供味觉替代品。苦味、甜味和鲜味(咸味)味道在细胞水平上由属于G蛋白偶联受体(GPCR)蛋白超家族的味觉受体家族(TASRs)检测。由于它们难以直接进行结构可视化,如X射线晶体学,因此对负责结合配体的TASRs的结构特征知之甚少。阐明TASR-配体结构相互作用可以开发与健康相关的产品,如苦味阻断剂和糖替代品。该提案的结果将使TASRs的配体以及可能的其他GPCR得以开发。公共卫生相关性:味觉配体目前用于掩盖厌恶的味道,改善患者的依从性,影响食物的选择,并改变热量摄入,因此经常影响日常人类活动。该提案将通过使用研究平台发现新的味觉配体来为人类健康做出贡献。
英文摘要
DESCRIPTION (provided by applicant): As the primary mechanism by which animals detect nutrient-rich foods and discriminate against toxins, the sense of taste has a significant impact on health and behavior. Bitter tastes are perceived with high sensitivity and broad specificity, and can evoke strong aversive reactions that influence health-related behaviors such as dietary preference and pharmaceutical compliance. Conversely, sweet taste facilitates the detection and consumption of high carbohydrate (and hence highly caloric) foods, but over-consumption of calories can lead to obesity and diabetes. It is therefore desirable in many circumstances to manipulate taste perception and/or to provide taste substitutes. Bitter, sweet, and umami (savory) tastes are detected at the cellular level by a family of taste receptors (TASRs), which belong to the G protein-coupled receptor (GPCR) superfamily of proteins. Because they are refractory to direct structural visualization such as x-ray crystallography, very little is known about the structural features of TASRs that are responsible for binding ligands. Elucidating TASR-ligand structural interactions could enable the development of health-related products, such as bitter blockers and sugar substitutes. The results of this proposal would enable ligands of TASRs, and possibly other GPCRs, to be developed. PUBLIC HEALTH RELEVANCE: Taste ligands are currently used to mask aversive tastes, improve patient compliance, influence choice of foods, and modify caloric intake, so routinely influence daily human activity. This proposal will contribute to human health by using a research platform to discover novel taste ligands.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Claudin MAbs for Treating Solid Tumors
  • 批准号:
    10482193
  • 项目类别:
  • 资助金额:
    $59.99万
  • 财政年份:
    2022
  • 负责人:
    JOSEPH Benjamin RUCKER
  • 依托单位:
Development of Claudin MAbs for Treating Solid Tumors
  • 批准号:
    10631161
  • 项目类别:
  • 资助金额:
    $70.93万
  • 财政年份:
    2022
  • 负责人:
    JOSEPH Benjamin RUCKER
  • 依托单位:
Development of Nav1.7 Monoclonal Antibodies for Treating Pain
  • 批准号:
    10318547
  • 项目类别:
  • 资助金额:
    $47.48万
  • 财政年份:
    2021
  • 负责人:
    JOSEPH Benjamin RUCKER
  • 依托单位:
Identifying Agonist MAbs against GPCRs
  • 批准号:
    9756430
  • 项目类别:
  • 资助金额:
    $13.22万
  • 财政年份:
    2018
  • 负责人:
    JOSEPH Benjamin RUCKER
  • 依托单位:
海外基金